These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 35443438)

  • 21. Survival and Evolution of Renal Function in Kidney Transplant Recipients From Type II Asystolic Donations: A Single-center Experience.
    Toapanta Gaibor NG; González-Roncero FM; Cintra Cabrera M; Suñer Poblet M; Bernal Blanco G; Suarez Benjumea A; Pérez-Valdivia MA; Egea-Guerrero JJ; Rocha Castilla JL; Gentil Govantes MA
    Transplant Proc; 2018 Mar; 50(2):565-568. PubMed ID: 29579853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Study Protocol for Better Evidence for Selecting Transplant Fluids (BEST-Fluids): a pragmatic, registry-based, multi-center, double-blind, randomized controlled trial evaluating the effect of intravenous fluid therapy with Plasma-Lyte 148 versus 0.9% saline on delayed graft function in deceased donor kidney transplantation.
    Collins MG; Fahim MA; Pascoe EM; Dansie KB; Hawley CM; Clayton PA; Howard K; Johnson DW; McArthur CJ; McConnochie RC; Mount PF; Reidlinger D; Robison L; Varghese J; Vergara LA; Weinberg L; Chadban SJ;
    Trials; 2020 May; 21(1):428. PubMed ID: 32450917
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The risk of allograft failure and the survival benefit of kidney transplantation are complicated by delayed graft function.
    Gill J; Dong J; Rose C; Gill JS
    Kidney Int; 2016 Jun; 89(6):1331-6. PubMed ID: 27165823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prolonged Ischemic Time, Delayed Graft Function, and Graft and Patient Outcomes in Live Donor Kidney Transplant Recipients.
    Krishnan AR; Wong G; Chapman JR; Coates PT; Russ GR; Pleass H; Russell C; He B; Lim WH
    Am J Transplant; 2016 Sep; 16(9):2714-23. PubMed ID: 27037866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delayed graft function in pediatric living donor kidney transplantation.
    Hwang CS; Kadakia Y; Sanchez-Vivaldi JA; Patel MS; Shah JA; DeGregorio L; Desai DM; Vagefi PA; MacConmara M
    Pediatr Transplant; 2023 Mar; 27(2):e14432. PubMed ID: 36369617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Outcomes of kidney transplant from deceased donors with acute kidney injury and prolonged cold ischemia time - a retrospective cohort study.
    Dube GK; Brennan C; Husain SA; Crew RJ; Chiles MC; Cohen DJ; Mohan S
    Transpl Int; 2019 Jun; 32(6):646-657. PubMed ID: 30712277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of pretransplant body mass index on early kidney graft function.
    Kieszek R; Kwiatkowski A; Jędrzejko K; Domagała P; Bieniasz M; Wszoła M; Drozdrowski J; Tomaszek A; Gozdowska J; Zygier D; Pączek L; Durlik M; Chmura A
    Transplant Proc; 2014 Oct; 46(8):2689-91. PubMed ID: 25380895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HLA-identical sibling renal transplantation--a 21-yr single-center experience.
    de Mattos AM; Bennett WM; Barry JM; Norman DJ
    Clin Transplant; 1999 Apr; 13(2):158-67. PubMed ID: 10202612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of graft and patient outcomes following kidney transplantation in extended hour and conventional haemodialysis patients.
    See EJ; Hawley CM; Cho Y; Toussaint ND; Agar JW; Pascoe EM; Lim WH; Francis RS; Collins MG; Johnson DW
    Nephrology (Carlton); 2019 Jan; 24(1):111-120. PubMed ID: 29316017
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Kidney transplantation in diabetic patients using cyclosporine. Five-year follow-up.
    Shaffer D; Simpson MA; Madras PN; Sahyoun AI; Conway PA; Davis CP; Monaco AP
    Arch Surg; 1995 Mar; 130(3):283-7; discussion 287-8. PubMed ID: 7887795
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predictors of Short-Term Outcomes in Living Donor Renal Allograft Recipients: A Prospective Study From a Tertiary Care Center in North India.
    John EE; Mehta S; Sohal PM; Sandhu JS
    Cureus; 2022 Aug; 14(8):e28335. PubMed ID: 36168334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rate, Factors, and Outcome of Delayed Graft Function After Kidney Transplantation of Deceased Donors.
    Jahn L; Rüster C; Schlosser M; Winkler Y; Foller S; Grimm MO; Wolf G; Busch M
    Transplant Proc; 2021 Jun; 53(5):1454-1461. PubMed ID: 33612277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peri-operative hyperglycemia is associated with delayed graft function in deceased donor renal transplantation.
    Parekh J; Roll GR; Feng S; Niemann CU; Hirose R
    Clin Transplant; 2013; 27(4):E424-30. PubMed ID: 23808826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors Associated With Delayed Graft Function and Their Influence on Outcomes of Kidney Transplantation.
    Salazar Meira F; Zemiacki J; Figueiredo AE; Viliano Kroth L; Saute Kochhann D; d'Avila DO; Traesel M; Saitovitch D; Poli-de-Figueiredo CE
    Transplant Proc; 2016 Sep; 48(7):2267-2271. PubMed ID: 27742276
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Donor positive blood culture is associated with delayed graft function in kidney transplant recipients: a propensity score analysis of the UNOS database.
    Huaman MA; Vilchez V; Mei X; Davenport D; Gedaly R
    Clin Transplant; 2016 Apr; 30(4):415-20. PubMed ID: 26840885
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction therapy by anti-thymocyte globulin (rabbit) versus basiliximab in deceased donor renal transplants and the effect on delayed graft function and outcomes.
    Foster CE; Weng RR; Piper M; Laugenou K; Ichii H; Lakey J; Malinoski D
    Transplant Proc; 2012 Jan; 44(1):164-6. PubMed ID: 22310605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recipient and donor body mass index as important risk factors for delayed kidney graft function.
    Weissenbacher A; Jara M; Ulmer H; Biebl M; Bösmüller C; Schneeberger S; Mayer G; Pratschke J; Öllinger R
    Transplantation; 2012 Mar; 93(5):524-9. PubMed ID: 22362367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Delayed Graft Function in Kidney Transplantation: Risk Factors and Impact on Early Graft Function.
    Tugmen C; Sert I; Kebabcı E; Murat Dogan S; Tanrısev M; Alparslan C; Kılıcaslan Ayna T; Olmez M; Karaca C
    Prog Transplant; 2016 Jun; 26(2):172-7. PubMed ID: 27207406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Duration of delayed graft function and its impact on graft outcomes in deceased donor kidney transplantation.
    Budhiraja P; Reddy KS; Butterfield RJ; Jadlowiec CC; Moss AA; Khamash HA; Kodali L; Misra SS; Heilman RL
    BMC Nephrol; 2022 Apr; 23(1):154. PubMed ID: 35440023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential Impact of Delayed Graft Function in Deceased Donor Renal Transplant Recipients With and Without Donor-specific HLA-antibodies.
    Haller J; Wehmeier C; Hönger G; Hirt-Minkowski P; Gürke L; Wolff T; Steiger J; Amico P; Dickenmann M; Schaub S
    Transplantation; 2019 Sep; 103(9):e273-e280. PubMed ID: 31205266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.